Position in IOVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,622,909
+$3,554,657 QoQ
Shares Held
1,032,168
+4028.5% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Derivatives in IOVA
reported options exposure · as of Dec 31, 2024CallValue
$114,700
CallShares
15,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. IOVA ranks #50 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
426,723 | $141,189,839 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
162,814 | $125,796,608 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,349,516 | $64,736,282 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
695,276 | $52,208,274 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
556,324 | $41,312,620 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
52,884 | $27,683,187 | |
| 7 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,103,490 | $25,998,224 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,705,829 | $24,666,287 |
All Filings in IOVA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,622,909 | 1,032,168 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $68,252 | 25,001 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $94,954 | 43,758 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,473,298 | 856,569 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $1,325,436 | 398,029 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $114,700 | 15,500 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $1,127,330 | 152,342 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,886,335 | 307,384 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,065,494 | 257,543 | Shares | Defined | 2024-08-14 | |
| 2023-09-30 | $584,861 | 128,541 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $254,371 | 41,632 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,528,409 | 368,310 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $358,740 | 21,546 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,359,352 | 123,591 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $810,352 | 32,861 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $224,406 | 9,100 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | $601,946 | 23,134 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $236,782 | 9,100 | Put | Defined | 2021-08-16 | |
| 2021-03-31 | $1,146,946 | 36,227 | Shares | Defined | 2021-05-17 | |
| 2021-03-31 | $288,106 | 9,100 | Put | Defined | 2021-05-17 | |
| 2020-09-30 | $416,108 | 12,640 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,617,086 | 131,770 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $203,891 | 6,810 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||